2F7124

Only health care professionals who have attained competency (as per institutional guidelines) should perform this procedure.

2F7122

Only health care professionals who have attained competency as per institutional guidelines in the safe administration, handling and waste management of cytotoxics, central venous access device care and CADD®-Solis VIP pump management should perform this procedure.

r5201-01

This document reflects what is currently regarded as safe practice. While every effort has been made to ensure the accuracy of the content at the time of publication, the Cancer Institute NSW does not accept any liability, with respect to loss, damage, injury or expense arising from any such errors or omission in the contents of this work. Any reference throughout the document to specific pharmaceuticals and/or medical products as examples does not imply endorsement of any of these products. While eviQ endeavours to link to reliable sources that provide accurate information, eviQ and the Cancer Institute NSW do not endorse or accept responsibility for the accuracy, currency, reliability or correctness of the content of linked external information source. Use is subject to eviQ’s disclaimer available at www.eviQ.org.au

This resource provides guidance on how to safely undertake the procedure. Institutional practice may vary in accordance with local policy.

2B1323Q

Sign up for our email newsletter that highlights product availability and shortage trends impacting your specific market.

Baxter 2F7124

JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Clinical safety note There are physical and operational differences between the different types of CADD® pumps. Incorrect programming can lead to over-infusion of medication and has the potential to cause serious injury and death. This protocol is for the CADD®-Solis VIP pump. This pump is designed for continuous and intermittent infusions of medication in mL/hour.

Disclaimer: TCC Pharma and its sister company, Urgent Surgery Solutions, have varied relationships with the manufacturers of the products we sell and distribute.  These companies have no direct affiliation with individual manufacturers. All brand names and trademarks are the property of their respective owners and are used for identification and informational purposes only.

Note: laboratory parameters or vital signs that are not within normal limits and/or patients with grade 2 or more toxicities should be referred to their medical officer for review prior to administration

We acknowledge the traditional custodians of the lands on which we work and live, and recognise their continuing connection to land, water and community. We pay our respect to Elders past and present.